|
Sign In to gain access to subscriptions and/or personal tools.
|
A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods
J Kassa
P.O. Box 35/T, Purkyné Military Medical Academy, 500 01 Hradec Králové, Czech Republic
J Cabal
Purkyné Military Medical Academy, Hradec Králové, Czech Republic
- 1 The reactivating and therapeutic efficacy of a new acetylcholinesterase reactivator, designated BI-6 (1-/2-hydroxyiminomethylpyridinium/-4-/carbamoylpyridinium/-2-butene dibromide), against organophosphate sarin was compared with presently used oximes (pralidoxime, obidoxime, methoxime) and H oximes (HI-6, HLö-7) by in vitro and in vivo methods.
- 2 Our results confirm that the new oxime BI-6 is a significantly more efficacious acetylcholinesterase reactivator than currently available pralidoxime and obidoxime but not as effective as H oximes (HI-6, HLö-7) in vitro as well as in vivo. In addition, the oxime BI-6 is able to protect supralethal sarin poisoned rats at human-relevant doses.
- 3 Our data also suggest that the potency of oximes tested to reactivate sarin-inhibited acetylcholinesterase in vitro closely corresponds to their reactivating efficacy in vivo and their ability to protect rats poisoned with supralethal doses of sarin.
Key Words: sarin pralidoxime obidoxime methoxime HI-6 HLö-7
Human & Experimental Toxicology, Vol. 18, No. 9,
560-565 (1999)
DOI: 10.1191/096032799678845106

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Kuca and J. Kassa
Oximes-induced reactivation of rat brain acetylcholinesterase inhibited by VX agent
Human and Experimental Toxicology,
April 1, 2004;
23(4):
167 - 171.
[Abstract]
[PDF]
|
 |
|
|
|